Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutants: the achilles' heel of human cancers?

Cell cycle (Georgetown, Tex.) - 1 Aug 2004

Brachmann Rainer K

Abstract excerpt

Recent scientific discoveries have thrust mutants of the tumor suppressor protein p53 into the forefront of the war on cancer, and hold out eventual hope for a small molecule drug that will be useful in treating human cancers with mutant p53 protein.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Neoplasms
Share to Tumor Suppressor Protein p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15280671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15280671-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutants: the achilles' heel of human cancers?PMID 15280671Read ↗

Targeting Mutated p53: Naivete and Enthusiasm to Attempt the Impossible.Semantic proximity Read ↗

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.Semantic proximity Read ↗

Rescuing the function of mutant p53.Semantic proximity Read ↗

Reviving the guardian of the genome: Small molecule activators of p53.Semantic proximity Read ↗

Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies.Semantic proximity Read ↗

p53 and human cancer: the first ten thousand mutations.Semantic proximity Read ↗

Strategies for manipulating the p53 pathway in the treatment of human cancer.Semantic proximity Read ↗

Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?Semantic proximity Read ↗

Unraveling the Guardian: p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies.Semantic proximity Read ↗

Side-Stepping the Guardian of the Genome: Current Cancer Therapeutics Targeting Mutant p53Semantic proximity Read ↗

p53: from understanding its structure to advances in therapeutic targeting.Semantic proximity Read ↗

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.